Sun Pharma recalls eye drug in the US

The recall was initiated by the company on January 21 this year, as per reports

recall1-1-jpg-475x310-q85

The company is recalling the drug for the presence of particulate matter

Sun Pharma has decide to recall 5,322 bottles of Ketorolac Tromethamine ophthalmic solution in the US market for failing to meet specifications. The ophthalmic solution falls under non-steroidal anti-inflammatory drug (NSAID) category and is indicated for relief from pain and inflammation in the eyes.

The company is recalling the drug for the presence of particulate matter in the 5,322 batch of bottles.

The drug was manufactured by the company's Halol facility in Gujarat.

It has been classified as a Class-II recall which FDA defined as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote".

 

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X